United States · FDA National Drug Code directory

Senna S

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
83324-135_36bb75f0-b291-4515-b49f-9ad4d80be637
Product NDC
83324-135
Form
TABLET
Composition / generic term
Docusate Sodium Sennosides
Labeler
QUALITY CHOICE (Chain Drug Marketing Association)
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20240731
Source listing expiry
20261231

Source-listed ingredients

  • DOCUSATE SODIUM — 50 mg/1
  • SENNOSIDES — 8.6 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE, PLASTIC in 1 BOX (83324-135-60) / 60 TABLET in 1 BOTTLE, PLASTIC · 83324-135-60

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Senna S — United States | Molindra Medicines